Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bio Key International (BKYI) Acquisitions (2020 - 2024)

Bio Key International (BKYI) has disclosed Acquisitions for 3 consecutive years, with $1869.0 as the latest value for Q1 2024.

Quarterly Acquisitions changed N/A to $1869.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $1869.0 through Mar 2024, down 97.66% year-over-year, with the annual reading at $623578.0 for FY2022, N/A changed from the prior year.
Acquisitions hit $1869.0 in Q1 2024 for Bio Key International, down from $80000.0 in the prior quarter.
In the past five years, Acquisitions ranged from a high of $543578.0 in Q1 2022 to a low of -$1.9 million in Q3 2020.
Historically, Acquisitions has averaged -$318451.5 across 3 years, with a median of $40934.5 in 2022.